Researchers continue to excited about the medication , a novel dual treatment showing significant data in early trials for size reduction . It works by modulating both hormones : GLP-1 and GIP, that , when stimulated, help influence cravings and improve calorie burn. Early findings suggest considerable size loss and likely advantages for individual